Q-122
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Q-122, covering 2021-07-23 to 2021-07-23. Get the full timeline:
Most recent: Clinical Trial Update: Safety/Efficacy of Q-122 in Breast Cancer Patients Taking Tamoxifen or Aromatase Inhibitor [Phase 2]